FDA Sends Warning Letters To Online Pharmacies Selling ADHD Drug, Adderall, Illegally


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


  • The FDA and the U.S. Drug Enforcement Administration have jointly issued warning letters to two websites for illegally selling Adderall, an attention deficit hyperactivity disorder (ADHD) treatment.
  • Kubapharm.com and Premiumlightssupplier.com were both accused of selling amphetamine drugs marketed as the ADHD drug Adderall without a prescription, according to an FDA statement. 
  • The agency also claims the pharmacies (which failed to register with the DEA) sold the medication without the proper labeling.
  • As Adderall has high abuse potential and “should only be used under the supervision of a licensed healthcare professional,” the FDA requires the medication to be sold with a black box warning outlining the risks.
  • Consumers should dispose of unused medicine from these websites and not purchase or use prescription drugs sold from these websites without a prescription, the agencies said in a statement.
  • The letters were issued on March 30, and according to the FDA, the websites will have 15 days to respond with specific steps for addressing their violations.

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: BiotechNewsHealth CareFDAGeneralBriefs